Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Author Archives: Mission IR

ARRIS Group, Inc. (ARRS) Starts Presentation at 25th Annual ROTH Conference

ARRIS Group is a worldwide communications technology company focused on designing, engineering and supplying communications and IP technologies that support broadband services for residential and business customers across the globe. The company provides broadband operators with the tools and platforms … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

MoSys, Inc. (MOSY) Starts Presentation at 25th Annual ROTH Conference

MoSys is an IP-rich fabless semiconductor company providing intelligent data access in network and communications systems. MOSY’s Bandwidth Engine® family of ICs combines the company’s patented 1T-SRAM® high-density, embedded memory and high-speed, 10 Gigabits per second serial interface with its … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Chembio Diagnostics, Inc. (CEMI) Starts Presentation at 25th Annual ROTH Conference

Chembio Diagnostics is a leading developer, manufacturer, licensor and marketer of point-of-care rapid diagnostic tests. The company’s two FDA PMA-approved, CLIA-waived rapid HIV tests are marketed in the United States by Alere, Inc., and the company markets its HIV STAT-PAK … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Repros Therapeutics, Inc. (RPRX) Starts Presentation at 25th Annual ROTH Conference

Repros Therapeutics develops products and services for the management of reproductive health. The company’s products include: contraceptives, vaccines for prostate cancer, enhanced topical treatment for genital herpes as well as treatments for male and female sexual dysfunction. RPRX focuses on … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Paramount Gold and Silver Corp. (PZG) Starts Presentation at 25th Annual ROTH Conference

Paramount Gold and Silver is an exploration and development company with multi-million ounce advanced stage precious metals projects in Nevada (Sleeper) and northern Mexico (San Miguel). The San Miguel Project consists of more than 353,000 acres in the Palmarejo District, … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Discovery Laboratories, Inc. (DSCO) Starts Presentation at 25th Annual ROTH Conference

Discovery Laboratories is a specialty biotechnology company engaged in the advancement of a new standard in respiratory critical care. The company’s novel proprietary KL4 surfactant technology creates a synthetic, peptide-containing surfactant that is similar in structure to pulmonary surfactant, and … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

JAKKS Pacific, Inc. (JAKK) Starts Presentation at 25th Annual ROTH Conference

JAKKS Pacific is a leading U.S. designer and marketer of toys and consumer products, offering a broad variety of products featuring popular brands and children’s toy licenses. The company’s diverse portfolio of products is sold under various proprietary brands, and … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Destination Maternity Corp. (DEST) Starts Presentation at 25th Annual ROTH Conference

Destination Maternity is a leading global designer and retailer of maternity apparel. As of Dec. 31, 2012, the company operated 1,887 retail locations – including 621 stores – in the U.S. and Canada, as well as 1,266 leased department locations. … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Senomyx, Inc. (SNMX) Starts Presentation at 25th Annual ROTH Conference

Senomyx utilizes its proprietary taste science technologies to discover and develop novel flavor ingredients. The company is also engaged in a new effort to discover and develop natural high-potency sweeteners. SNMX has collaborative agreements with global food, beverage, and ingredient … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Trinity Biotech plc (TRIB) Starts Presentation at 25th Annual ROTH Conference

Trinity Biotech acquires, develops, manufactures, distributes and sells diagnostic test kits and instrumentation for the clinical laboratory and point-of-care segments of the diagnostic market. Among other offerings, TRIB provides clinical laboratory products, including diagnostic tests and instrumentation, which detect autoimmune, … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment